A senior BMW executive chose a curious moment to back the company with hard cash. On the same Friday the...

The divergence between Ocugen's scientific trajectory and its stock price has rarely been starker. The biotech's shares closed at €1.05...

A year of extraordinary gains — nearly 900% — has given way to a more measured tone for European Lithium....

Just 5.7% of OHB's shares currently change hands freely — a structural bottleneck that has turned the stock into a...

The Vanguard FTSE All‑World UCITS ETF enters this week within striking distance of its all‑time high, but the path to...

Nel ASA settled its legal dispute with Iwatani Corporation of America on June 7, agreeing to pay $7.5 million to...

Investors delivered a stark verdict on Redwood AI last week, sending shares into a tailspin even as the company unveiled...

The numbers tell two completely different stories. DeFi Technologies booked $11.2 million in revenue and $4.9 million in net profit...

Shareholders backed the board, management touted drone-mounted sensors for greenhouses, and the stock surged more than 6% on Friday –...

Partners Group is running a high-wire act. The Swiss private-markets giant is pushing ahead with a $1.5 billion real estate...